Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Diabetes Research and Clinical Practice|October 21, 2006
Beta-cell preservation with thiazolidinedionesIan W Campbell, Segundo MarizInternational Journal of Pharmaceutics|April 11, 2012
The development and registration of topical pharmaceuticalsChristopher J Mugglestone, Segundo Mariz, Majella E LaneDiabetes & Vascular Disease Research|October 2, 2007
Long-term effects of pioglitazone versus gliclazide on hepatic and humoral coagulation factors in patients with type 2 diabetesGabriele Perriello, Simone Pampanelli, Paolo Brunetti, et al.Journal of the History of Ideas|August 2, 2016
John Punch, Scotist Holy War, and the Irish Catholic Revolutionary Tradition in the Seventeenth CenturyIan W CampbellOrphanet Journal of Rare Diseases|January 23, 2017
Evolving prevalence of haematological malignancies in orphan designation procedures in the European UnionBenedetta Polsinelli, Stelios Tsigkos, Frauke Naumann-Winter, et al.Pharmacoeconomics|December 29, 2006
A lifetime modelled economic evaluation comparing pioglitazone and rosiglitazone for the treatment of type 2 diabetes mellitus in the UKDominic P Tilden, Segundo Mariz, Gillies O'Bryan-Tear, et al.Frontiers in Medicine|July 12, 2021
Regulatory Standards in Orphan Medicinal Product Designation in the EUStelios Tsigkos, Segundo Mariz, Maria Elzbieta Sheean, et al.British Journal of Clinical Pharmacology|March 27, 2021
Haemophilia, state of the art and new therapeutic opportunities, a regulatory perspectiveFrancesca Tomeo, Segundo Mariz, Angelo Loris Brunetta, et al.Frontiers in Medicine|June 1, 2017
Advanced Therapy Medicinal Products for Rare Diseases: State of Play of Incentives Supporting Development in EuropeAndreas M Farkas, Segundo Mariz, Violeta Stoyanova-Beninska, et al.Molecular Biology of the Cell|February 20, 2020
Spindle pole bodies function as signal amplifiers in the Mitotic Exit NetworkIan W Campbell, Xiaoxue Zhou, Angelika AmonPageof 4